Showing results (1-10 of 152) with videos related to
Sort By:
Pageof 16
Targeted Oncology|November 30, 2011
Heart to heart with trastuzumab: a review on cardiac toxicitySerena Di CosimoCancer Drug Resistance (Alhambra, Calif.)|April 17, 2023
Concomitant medications and circulating tumor cells: friends or foes?Serena Di Cosimo, Vera CappellettiNPJ Breast Cancer|May 12, 2026
Beyond timing, toward precision: insights from CDK4/6 inhibitor trials in metastatic breast cancerSerena Di Cosimo, Giovanni ApoloneEuropean Journal of Cancer (Oxford, England : 1990)|November 18, 2008
Targeted therapies in breast cancer: where are we now?Serena Di Cosimo, José BaselgaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Phosphoinositide 3-kinase mutations in breast cancer: a "good" activating mutation?Serena Di Cosimo, José BaselgaNature Reviews. Clinical Oncology|February 4, 2010
Management of breast cancer with targeted agents: importance of heterogeneity. [corrected]Serena Di Cosimo, José BaselgaBreast (Edinburgh, Scotland)|December 22, 2020
CDK 4/6 inhibitors mired in uncertainty in HR positive and HER2 negative early breast cancerSerena Di Cosimo, Luca Porcu, Fatima CardosoCancer Treatment Reviews|November 30, 2013
microRNAs in breast cancer development and treatmentDanila Serpico, Leonardo Molino, Serena Di CosimoPharmacogenomics and Personalized Medicine|January 10, 2014
Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patientsAnna Tessari, Dario Palmieri, Serena Di CosimoBreast (Edinburgh, Scotland)|January 8, 2014
Neoadjuvant treatment of HER2 and hormone-receptor positive breast cancer - moving beyond pathological complete responseSerena Di Cosimo, Grazia Arpino, Daniele GeneraliPageof 16